67.62歐元0.64(0.96%)
2024/07/25更新
績效 / 1月3.27%
3月10.19%
1年6.36%
晨星評等-
淨值走勢
基金總覽
基金規模16,250.81百萬截至 2021-01-21
持股明細 / 風險評估
- 1.美國67.68%
- 2.歐洲不包含歐元區12.03%
- 3.歐元區6.40%
- 4.日本2.84%
- 5.英國2.71%
- 1.健康護理94.71%
- 2.基本物料0.53%
- 3.金融服務0.35%
- 1.Eli Lilly and Co8.24%
- 2.Novo Nordisk A/S Class B7.67%
- 3.UnitedHealth Group Inc5.91%
- 4.Boston Scientific Corp4.39%
- 5.AbbVie Inc4.04%
- 1.美國67.68%
- 2.歐洲不包含歐元區12.03%
- 3.歐元區6.40%
- 4.日本2.84%
- 5.英國2.71%
- 1.Eli Lilly and Co8.24%
- 2.Novo Nordisk A/S Class B7.67%
- 3.UnitedHealth Group Inc5.91%
- 4.Boston Scientific Corp4.39%
- 5.AbbVie Inc4.04%
- 1.健康護理94.71%
- 2.基本物料0.53%
- 3.金融服務0.35%